We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maxcyte Inc | LSE:MXCT | London | Ordinary Share | COM STK USD0.01 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 1.37% | 370.00 | 370.00 | 380.00 | 375.00 | 365.00 | 365.00 | 30,953 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 41.29M | -37.92M | -0.3664 | -12.91 | 489.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/9/2021 09:36 | Just quoting the figures from the accounts mysteronz. Perhaps you have better figures. | trident5 | |
14/9/2021 09:25 | Trident hasn’t got a clue basically. | mysteronz | |
14/9/2021 09:21 | I think that was stock option revaluation due to the increase in the share price | wjccghcc | |
14/9/2021 08:58 | In the accounts: revenue grew by $2.3m and compensation by $5.8m!! | trident5 | |
14/9/2021 08:37 | Trident5 - where are compensation increases disclosed? | adamb1978 | |
14/9/2021 08:04 | Placing cash funding big compensation increases. | trident5 | |
14/9/2021 07:44 | Transcript of last night's call | homebrewruss | |
13/9/2021 21:49 | Just listening to the conference call. Not sure that I've heard much to move things in either direction at the moment, or much different, though I guess its a long-term story stock to that shouldnt be a surprise | adamb1978 | |
09/9/2021 18:14 | All grist to the mill!. I wonder what this particular approval will be worth to Maxcyte. | assagai | |
09/9/2021 16:49 | Fast track approval for Maxcyte partner drug. | acuere | |
09/9/2021 10:05 | Strange number of zero trades going thru. Including one at 20:20 last night shown at a price of 1234.9845p Any thoughts what these mean? | acuere | |
09/9/2021 08:48 | Sorry wrong thread | big7ime | |
07/9/2021 19:38 | Another blog/note on MXCT 'MaxCyte's snowball effect: Riding on the shoulders of top CRISPR companies' | homebrewruss | |
06/9/2021 18:30 | Interesting blog posting on Maxcyte MaxCyte: Enabling Next-Generation Cell Based Therapies, Attractive Risk-Return Profile. | pob69 | |
06/9/2021 14:03 | It's Labor Day in the US, so we're "all on our own" today | thetrotsky | |
03/9/2021 22:59 | 190k after hours sell. So 2million squids worth moved into new hands. Nice base. | assagai | |
02/9/2021 16:20 | Philip Rodrigs, manager of Raynar Flagship fund, explains why he invests in life sciences company MaxCyte (MXCT). | pob69 | |
02/9/2021 13:41 | Thanks Pob69, a week earlier than anticipated. Well its on my NAS monitor but not UK? | assagai | |
02/9/2021 13:17 | Hasn't been RNSed but Q2 out on 13/9 | pob69 | |
02/9/2021 08:35 | Filtering is not enough for me, multibagger. Although I hope you stay on 😊 I've removed MXCT from my favourites list. Pity, but look at the other boards that have been destroyed by trolls and folks feeding them. BOO is a good current example. I suspect that a lot of (mostly) lurkers disappear too. Such a shame. apad | apad | |
02/9/2021 08:08 | T5, Stop being a numpty yourself. The Investopedia definition is misleading. A company's share price at any given time is generally accepted to represent the market's notional estimate of its discounted future earnings (the present value of future cash flows; generally, but not always, less than the actual cash flows) plus the market value (or cash value if you prefer) of its net assets as at that date. I would accept that, in principle, my share of the company's discounted future earnings has (potentially) been reduced by the new share issue but the company's net assets have been enhanced (by the additional cash) and, because the new shares were issued at a premium, the new investors have effectively (more than) compensated me for the expected reduction in my share of the discounted future earnings. As I've already said, a new share issue at a (significant) premium is extremely rare in my experience. Furthermore, I say "potentially" because although the new investment may not change the company's expected future earnings it may have accelerated them, with a consequential knock on effect that the company's discounted future earnings may well have increased. It's all in the maths. | thetrotsky | |
02/9/2021 07:09 | Good morning Nimbo1 and Assagai, I have added another to the "filtered" crew now....best to leave them to their style of investing. | multibagger | |
01/9/2021 23:03 | So proud mum and dad go to Johnny's passing out parade. The band strikes up, the cadets go by the left, quick march. Mum turns to Dad in horror and exclaims. "I don't believe it , just look at that, every single one of them is marching out of step......except our little Johnny of course. | assagai | |
01/9/2021 22:40 | For the numpties: | trident5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions